1. Allogeneic Bone Marrow Transplantation in First Remission for Children with Ultra-high- risk Features of Acute Lymphoblastic Leukemia: A Children’s Oncology Group Study Report 
Prakash Satwani, Harland Sather, Fevzi Ozkaynak, Nyla A. Heerema, Kirk R. Schultz, Jean Sanders, John Kersey, Virginia Davenport, Michael Trigg, Mitchell S. Cairo 
Biology of Blood and Marrow Transplantation 
Volume 13, Issue 2, Pages (February 2007)
DOI: /j.bbmt
Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Probability of 5-year event-free survival (EFS) by Kaplan-Meier estimates in children with ultra-high-risk features of acute lymphoblastic leukemia in first complete remission treated with allogeneic bone marrow transplantation in the Children’s Cancer Group 1921 study.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Probability of 5-year event-free survival (EFS) by Kaplan-Meier estimates in children with Philadelphia chromosome-positive t(9;22) acute lymphoblastic leukemia in first complete remission treated with allogeneic bone marrow transplantation in the Children’s Cancer Group 1921 study.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions